Emcure Pharmaceuticals (NSEI:EMCURE) - Stock Price, News & Analysis

EMCURE Stock Overview

Engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. More details

EMCURE fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	4/6
Past Performance	2/6
Financial Health	6/6
Dividends	0/6

Rewards

Earnings are forecast to grow 25.34% per year

Analysts in good agreement that stock price will rise by 27.7%

Risk Analysis

No risks detected for EMCURE from our risk checks.

Emcure Pharmaceuticals Limited Competitors

Laurus Labs

NSEI:LAURUSLABS

₹263.6b

J. B. Chemicals & Pharmaceuticals

BSE:506943

₹258.7b

NATCO Pharma

NSEI:NATCOPHARM

₹244.4b

Pfizer

NSEI:PFIZER

₹236.9b

Price History & Performance

Summary of all time highs, changes and price drops for Emcure Pharmaceuticals
Historical stock prices
Current Share Price	₹1,283.80
52 Week High	₹1,580.00
52 Week Low	₹1,225.00
Beta	0
11 Month Change	-7.95%
3 Month Change	-7.32%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-5.54%

Recent updates

Shareholder Returns

	EMCURE	IN Pharmaceuticals	IN Market
7D	-5.5%	-0.2%	0.3%
1Y	n/a	40.5%	27.3%

Return vs Industry: Insufficient data to determine how EMCURE performed against the Indian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how EMCURE performed against the Indian Market.

Price Volatility

Is EMCURE's price volatile compared to industry and market?
EMCURE volatility
EMCURE Average Weekly Movement	5.2%
Pharmaceuticals Industry Average Movement	6.0%
Market Average Movement	6.1%
10% most volatile stocks in IN Market	9.2%
10% least volatile stocks in IN Market	4.0%

Stable Share Price: EMCURE has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine EMCURE's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1981	10,852	Satish Mehta	www.emcure.com

Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, dermatology, and other areas, as well as vitamins, minerals, and nutrients. The company also develops products across various platforms, including chiral molecules, complex APIs, orals, iron products, photo-chemistry products, liposomal and lyophilized injectables, high potency drugs, biotherapeutics, and novel drug delivery systems.

Emcure Pharmaceuticals Limited Fundamentals Summary

How do Emcure Pharmaceuticals's earnings and revenue compare to its market cap?
EMCURE fundamental statistics
Market cap	₹246.85b
Earnings (TTM)	₹5.67b
Revenue (TTM)	₹72.56b

42.8x

P/E Ratio

3.3x

P/S Ratio

Is EMCURE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EMCURE income statement (TTM)
Revenue	₹72.56b
Cost of Revenue	₹28.25b
Gross Profit	₹44.31b
Other Expenses	₹38.64b
Earnings	₹5.67b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	30.01
Gross Margin	61.07%
Net Profit Margin	7.82%
Debt/Equity Ratio	21.9%

How did EMCURE perform over the long term?

See historical performance and comparison

Emcure Pharmaceuticals NSEI:EMCURE Stock Report